Abstract
Retrievable inferior vena cava (IVC) filter use has increased over 115% since the Food and Drug Administration (FDA) approval in 2009. Likewise, there has been a marked increase in complications related to their increased use. In 2014 the FDA, recognizing both the high rate of new complications and
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have